Kenneth McClain

25PUBLICATIONS
84CO-AUTHORS
Haematological tumoursHaematologyPharmacogenomicsMedical infection agents (incl. prions)Econometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 13, 2026
Clofarabine for relapsed/refractory LCH and non-LC histiocytosis.

|May 08, 2026
Disease extent, not lesion location, determines relapse risk in single-system skeletal Langerhans cell histiocytosis.

|Apr 02, 2026
Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.

Emily Leung, Nicholas R Fragola, Elliott W Sharp

|Mar 31, 2026
Consensus recommendations for malignant histiocytic neoplasms (histiocytic, Langerhans, and interdigitating dendritic cell sarcomas).

Gaurav Goyal, Oussama Abla, John K C Chan

|Jan 15, 2026
Disordered differentiation and cellular senescence in pediatric Hodgkin Reed-Sternberg cells.

Jennifer E Agrusa, Elmoataz Abdel Fattah, Howard Lin

|Apr 25, 2025
Taking a break: a therapeutic option for ECD?

Matthias Papo, Kenneth McClain

Pageof 5

Frequent Collaborators

6 joint publications

Jennifer Picarsic

6 joint publications

Nitya Gulati

4 joint publications

Carl E Allen

4 joint publications

Olive Simone Eckstein